...
首页> 外文期刊>Cell cycle >The SWI/SNF ATPase BRG1 stimulates DNA end resection and homologous recombination by reducing nucleosome density at DNA double strand breaks and by promoting the recruitment of the CtIP nuclease
【24h】

The SWI/SNF ATPase BRG1 stimulates DNA end resection and homologous recombination by reducing nucleosome density at DNA double strand breaks and by promoting the recruitment of the CtIP nuclease

机译:SWI / SNF ATP酶BRG1通过降低DNA双链中的核心密度并通过促进CTIP核酸酶的募集来刺激DNA结束切除和同源重组。

获取原文
获取原文并翻译 | 示例
           

摘要

DNA double strand breaks (DSBs) are among the most toxic DNA lesions and can be repaired accurately through homologous recombination (HR). HR requires processing of the DNA ends by nucleases (DNA end resection) in order to generate the required single-stranded DNA (ssDNA) regions. The SWI/SNF chromatin remodelers are 10-15 subunit complexes that contain one ATPase (BRG1 or BRM). Multiple subunits of these complexes have recently been identified as a novel family of tumor suppressors. These complexes are capable of remodeling chromatin by pushing nucleosomes along the DNA. More recent studies have identified these chromatin remodelers as important factors in DNA repair. Using the DR-U2OS reporter system, we show that the down regulation of BRG1 significantly reduces HR efficiency, while BRM has a minor effect. Inactivation of BRG1 impairs DSB repair and results in a defect in DNA end resection, as measured by the amount of BrdU-containing ssDNA generated after DNA damage. Inactivation of BRG1 also impairs the activation of the ATR kinase, reduces the levels of chromatin-bound RPA, and reduces the number of RPA and RAD51 foci after DNA damage. This defect in DNA end resection is explained by the defective recruitment of GFP-CtIP to laser-induced DSBs in the absence of BRG1. Importantly, we show that BRG1 reduces nucleosome density at DSBs. Finally, inactivation of BRG1 renders cells sensitive to anti-cancer drugs that induce DSBs. This study identifies BRG1 as an important factor for HR, which suggests that BRG1-mutated cancers have a DNA repair vulnerability that can be exploited therapeutically.
机译:DNA双链断裂(DSB)是最具毒性的DNA损伤之一,可以通过同源重组(HR)进行精确修复。HR需要通过核酸酶处理DNA末端(DNA末端切除),以生成所需的单链DNA(ssDNA)区域。SWI/SNF染色质重塑体是包含一种ATP酶(BRG1或BRM)的10-15个亚单位复合物。这些复合物的多个亚基最近被确定为一个新的肿瘤抑制家族。这些复合物能够通过沿着DNA推动核小体来重塑染色质。最近的研究表明,这些染色质重塑体是DNA修复的重要因素。使用DR-U2OS reporter系统,我们发现BRG1的下调显著降低了人力资源效率,而BRM的影响较小。BRG1失活会损害DSB修复,并导致DNA末端切除缺陷,这是通过DNA损伤后产生的含有BrdU的单链DNA量来衡量的。BRG1失活也会损害ATR激酶的激活,降低染色质结合RPA的水平,并减少DNA损伤后RPA和RAD51病灶的数量。这种DNA末端切除的缺陷可以解释为在缺乏BRG1的情况下,GFP-CtIP对激光诱导的DSB的招募缺陷。重要的是,我们发现BRG1降低了DSB处的核小体密度。最后,BRG1的失活使细胞对诱导DSB的抗癌药物敏感。这项研究确定BRG1是HR的一个重要因素,这表明BRG1突变的癌症具有DNA修复的脆弱性,可用于治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号